Senzo Receives Funding from the Biomedical Advanced Research and Development Authority (BARDA) to Advance Its PCR-Accurate Lateral Flow COVID-19 Test

See more here


Venatorx Pharmaceuticals Presents Data on Investigational Cefepime-Taniborbactam at IDWeek 2022

Superior to Meropenem for the Primary Efficacy Endpoint

Safety Profile Consistent with Meropenem

See more here


Treventis Awarded $2.97M Grant from the U.S. Department of Defense

Funds for Development of Its Anti-Tau Drug Against Neurodegenerative Diseases

See more here


Wellsheet Introduces EHR Workflow Relief to Increase Efficiency During Critical Nursing Shortage

Virtual Nursing Station with Real-Time Notifications Increases Care Team Collaboration and Patient Care Quality

See more here


Relmada Therapeutics Announces Top-line Results from Phase 3 RELIANCE III Trial for REL-1017 as a Monotherapy for the Treatment of Major Depressive Disorder

See more here


Annovis Bio Announces┬áPublication of Phase 2a Clinical Data in The Journal of Prevention of Alzheimer’s Disease

See more here


Annovis Bio Announces FDA Authorization to Proceed with Phase 2/3 Trial for Buntanetap in Alzheimer’s Disease

See more here


Venatorx Pharmaceuticals Awarded BARDA Project BioShield Contract

Total award of up to $318M for development and procurement of novel antibiotic cefepime-taniborbactam for the treatment of melioidosis and multi-drug resistant infections

See more here


Relmada Therapeutics Announces Completion of Treatment in Company’s Registrational Phase 3 RELIANCE III Trial for REL-1017 as a Monotherapy for Major Depressive Disorder

See more here